BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26238631)

  • 1. PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells.
    Kherrouche Z; Monte D; Werkmeister E; Stoven L; De Launoit Y; Cortot AB; Tulasne D; Chotteau-Lelievre A
    Mol Oncol; 2015 Nov; 9(9):1852-67. PubMed ID: 26238631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of a negative feedback loop involving pea3 and cyclin d2 is required for pea3-induced migration in transformed mammary epithelial cells.
    Ladam F; Damour I; Dumont P; Kherrouche Z; de Launoit Y; Tulasne D; Chotteau-Lelievre A
    Mol Cancer Res; 2013 Nov; 11(11):1412-24. PubMed ID: 23989931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.
    Cowden Dahl KD; Zeineldin R; Hudson LG
    Mol Cancer Res; 2007 May; 5(5):413-21. PubMed ID: 17475671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MET activation in determining the sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors.
    Rho JK; Choi YJ; Lee JK; Ryoo BY; Na II; Yang SH; Lee SS; Kim CH; Yoo YD; Lee JC
    Mol Cancer Res; 2009 Oct; 7(10):1736-43. PubMed ID: 19808904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function and regulation of the PEA3 subfamily of ETS transcription factors in cancer.
    Qi T; Qu Q; Li G; Wang J; Zhu H; Yang Z; Sun Y; Lu Q; Qu J
    Am J Cancer Res; 2020; 10(10):3083-3105. PubMed ID: 33163259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma.
    Keld R; Guo B; Downey P; Gulmann C; Ang YS; Sharrocks AD
    Mol Cancer; 2010 Dec; 9():313. PubMed ID: 21143918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
    Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
    Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEA3 activates CXCR4 transcription in MDA-MB-231 and MCF7 breast cancer cells.
    Gu S; Chen L; Hong Q; Yan T; Zhuang Z; Wang Q; Jin W; Zhu H; Wu J
    Acta Biochim Biophys Sin (Shanghai); 2011 Oct; 43(10):771-8. PubMed ID: 21831961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Met signaling is required for recruitment of motor neurons to PEA3-positive motor pools.
    Helmbacher F; Dessaud E; Arber S; deLapeyrière O; Henderson CE; Klein R; Maina F
    Neuron; 2003 Aug; 39(5):767-77. PubMed ID: 12948444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness.
    Schmidt U; Heller G; Timelthaler G; Heffeter P; Somodi Z; Schweifer N; Sibilia M; Berger W; Csiszar A
    J Exp Clin Cancer Res; 2021 Feb; 40(1):69. PubMed ID: 33596971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
    Lynch CC; Crawford HC; Matrisian LM; McDonnell S
    Int J Oncol; 2004 Jun; 24(6):1565-72. PubMed ID: 15138601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase.
    O'Hagan RC; Hassell JA
    Oncogene; 1998 Jan; 16(3):301-10. PubMed ID: 9467955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription.
    Firlej V; Ladam F; Brysbaert G; Dumont P; Fuks F; de Launoit Y; Benecke A; Chotteau-Lelievre A
    J Cell Sci; 2008 Oct; 121(Pt 20):3393-402. PubMed ID: 18827017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PEA3 group of ETS-related transcription factors. Role in breast cancer metastasis.
    de Launoit Y; Chotteau-Lelievre A; Beaudoin C; Coutte L; Netzer S; Brenner C; Huvent I; Baert JL
    Adv Exp Med Biol; 2000; 480():107-16. PubMed ID: 10959416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Activation upon MET and ALK Coamplification Sustains Targeted Therapy in Sarcomatoid Carcinoma, a Deadly Subtype of Lung Cancer.
    Pelosi G; Gasparini P; Conte D; Fabbri A; Perrone F; Tamborini E; Pupa SM; Ciravolo V; Caserini R; Rossi G; Cavazza A; Papotti M; Nakatani Y; Maisonneuve P; Pastorino U; Sozzi G
    J Thorac Oncol; 2016 May; 11(5):718-728. PubMed ID: 26804638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI-Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation.
    Yamaoka T; Ohmori T; Ohba M; Arata S; Kishino Y; Murata Y; Kusumoto S; Ishida H; Shirai T; Hirose T; Ohnishi T; Sasaki Y
    Mol Cancer Ther; 2016 Dec; 15(12):3040-3054. PubMed ID: 27612490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ets transcription factors of the PEA3 group: transcriptional regulators in metastasis.
    de Launoit Y; Baert JL; Chotteau-Lelievre A; Monte D; Coutte L; Mauen S; Firlej V; Degerny C; Verreman K
    Biochim Biophys Acta; 2006 Aug; 1766(1):79-87. PubMed ID: 16546322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors.
    Xie Y; Cao Z; Wong EW; Guan Y; Ma W; Zhang JQ; Walczak EG; Murphy D; Ran L; Sirota I; Wang S; Shukla S; Gao D; Knott SR; Chang K; Leu J; Wongvipat J; Antonescu CR; Hannon G; Chi P; Chen Y
    J Clin Invest; 2018 Apr; 128(4):1442-1457. PubMed ID: 29360641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma.
    Keld R; Guo B; Downey P; Cummins R; Gulmann C; Ang YS; Sharrocks AD
    Br J Cancer; 2011 Jun; 105(1):124-30. PubMed ID: 21673681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.